• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

螯合疗法通过调节铜转运蛋白抑制肾纤维化。

Copper chelation therapy inhibits renal fibrosis by modulating copper transport proteins.

机构信息

Department of Biological Sciences (Regulatory Toxicology), National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.

出版信息

Biofactors. 2022 Jul;48(4):934-945. doi: 10.1002/biof.1837. Epub 2022 Mar 24.

DOI:10.1002/biof.1837
PMID:35322483
Abstract

The copper (Cu) transporter proteins play an important role in the maintenance of the Cu homeostasis in the body. Lysyl oxidase (LOX) proteins are involved in crosslinking of collagens and elastin molecules resulting in the establishment of extracellular matrix (ECM) and require Cu for their functional activity. Although there are few reports showing the protective effects of Cu chelators, the mechanism behind protection remains unknown. The present study investigated the role of Cu transporter proteins in renal fibrosis. We used tubular epithelial cells and three different animal models of renal injury to investigate the induction of Cu transporter proteins in renal injury with different etiology. We used disulfiram, clioquinol as two Cu chelators and ammonium tetrathiomolybdate as a standard Cu chelator. In addition, β-aminopropionitrile (BAPN) was used as a standard LOX inhibitor. We demonstrated that renal fibrosis is associated with the induction of Cu transporter proteins such as ATP7A and Copper Transporter 1 (CTR1) but the Cu overload did not induce renal fibrosis. In addition, the Cu chelators inhibited renal fibrosis by inhibiting the Cu transporter proteins.

摘要

铜 (Cu) 转运蛋白在维持体内 Cu 平衡中发挥重要作用。赖氨酰氧化酶 (LOX) 蛋白参与胶原蛋白和弹性蛋白分子的交联,从而建立细胞外基质 (ECM),并需要 Cu 来发挥其功能活性。尽管有一些报道显示 Cu 螯合剂具有保护作用,但保护背后的机制仍不清楚。本研究探讨了 Cu 转运蛋白在肾脏纤维化中的作用。我们使用肾小管上皮细胞和三种不同的肾脏损伤动物模型,研究了不同病因引起的肾脏损伤中 Cu 转运蛋白的诱导。我们使用了二硫代二戊腈、氯喹酸作为两种 Cu 螯合剂,以及四硫钼酸铵作为标准 Cu 螯合剂。此外,β-氨基丙腈 (BAPN) 被用作标准 LOX 抑制剂。我们证明,肾脏纤维化与 Cu 转运蛋白(如 ATP7A 和铜转运蛋白 1 (CTR1))的诱导有关,但 Cu 过载不会引起肾脏纤维化。此外,Cu 螯合剂通过抑制 Cu 转运蛋白抑制肾脏纤维化。

相似文献

1
Copper chelation therapy inhibits renal fibrosis by modulating copper transport proteins.螯合疗法通过调节铜转运蛋白抑制肾纤维化。
Biofactors. 2022 Jul;48(4):934-945. doi: 10.1002/biof.1837. Epub 2022 Mar 24.
2
Disulfiram prevents collagen crosslinking and inhibits renal fibrosis by inhibiting lysyl oxidase enzymes.双硫仑通过抑制赖氨酰氧化酶抑制胶原交联,从而抑制肾纤维化。
J Cell Physiol. 2022 May;237(5):2516-2527. doi: 10.1002/jcp.30717. Epub 2022 Mar 13.
3
Elevated intracellular copper contributes a unique role to kidney fibrosis by lysyl oxidase mediated matrix crosslinking.细胞内铜水平升高通过赖氨酰氧化酶介导的基质交联对肾纤维化起独特作用。
Cell Death Dis. 2020 Mar 31;11(3):211. doi: 10.1038/s41419-020-2404-5.
4
Copper Transporter ATP7A (Copper-Transporting P-Type ATPase/Menkes ATPase) Limits Vascular Inflammation and Aortic Aneurysm Development: Role of MicroRNA-125b.铜转运 ATP7A(铜转运 P 型 ATP 酶/ Menkes ATP 酶)限制血管炎症和主动脉瘤的发展:微小 RNA-125b 的作用。
Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2320-2337. doi: 10.1161/ATVBAHA.119.313374. Epub 2019 Sep 26.
5
Upregulated copper transporters in hypoxia-induced pulmonary hypertension.缺氧诱导的肺动脉高压中铜转运蛋白上调。
PLoS One. 2014 Mar 10;9(3):e90544. doi: 10.1371/journal.pone.0090544. eCollection 2014.
6
Involvement of CTR1 and ATP7A in lead (Pb)-induced copper (Cu) accumulation in choroidal epithelial cells.CTR1 和 ATP7A 参与了脉络膜上皮细胞中铅(Pb)诱导的铜(Cu)积累。
Toxicol Lett. 2014 Feb 10;225(1):110-8. doi: 10.1016/j.toxlet.2013.11.034. Epub 2013 Dec 6.
7
Cancer Pro-oxidant Therapy Through Copper Redox Cycling: .通过铜氧化还原循环进行癌症促氧化疗法:
Curr Pharm Des. 2020;26(35):4461-4466. doi: 10.2174/1381612826666200628022113.
8
Inhibition of lysyl oxidase ameliorates renal injury by inhibiting CD44-mediated pericyte detachment and loss of peritubular capillaries.赖氨酰氧化酶抑制物通过抑制 CD44 介导的周细胞脱离和肾小管周毛细血管丢失来改善肾损伤。
Life Sci. 2020 Feb 15;243:117294. doi: 10.1016/j.lfs.2020.117294. Epub 2020 Jan 9.
9
Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.三乙烯四胺螯合铜在治疗糖尿病和阿尔茨海默病中的治疗潜力。
Drugs. 2011 Jul 9;71(10):1281-320. doi: 10.2165/11591370-000000000-00000.
10
Disruption of copper-dependent signaling pathway in the nitrofen-induced congenital diaphragmatic hernia.在除草醚诱导的先天性膈疝中铜依赖性信号通路的破坏
Pediatr Surg Int. 2015 Jan;31(1):31-5. doi: 10.1007/s00383-014-3620-9. Epub 2014 Oct 16.

引用本文的文献

1
Association between copper exposure and renal fibrosis in patients with chronic kidney disease: evidence from Mendelian randomization and a retrospective study.慢性肾脏病患者铜暴露与肾纤维化之间的关联:孟德尔随机化和一项回顾性研究的证据
Front Public Health. 2025 Aug 25;13:1657180. doi: 10.3389/fpubh.2025.1657180. eCollection 2025.
2
Copper-instigated modulatory cell mortality mechanisms and progress in kidney diseases.铜引发的调节性细胞死亡机制与肾脏疾病研究进展
Ren Fail. 2025 Dec;47(1):2431142. doi: 10.1080/0886022X.2024.2431142. Epub 2025 Jan 13.
3
Deciphering the contributions of cuproptosis in the development of hypertrophic scar using single-cell analysis and machine learning techniques.
利用单细胞分析和机器学习技术解析铜死亡在肥厚性瘢痕发展中的作用。
Front Immunol. 2023 Jun 20;14:1207522. doi: 10.3389/fimmu.2023.1207522. eCollection 2023.
4
Urinary Copper Excretion Is Associated with Long-Term Graft Failure in Kidney Transplant Recipients.尿铜排泄与肾移植受者的长期移植物失败相关。
Am J Nephrol. 2023;54(9-10):425-433. doi: 10.1159/000531147. Epub 2023 May 19.
5
The Combined Administration of Vitamin C and Copper Induces a Systemic Oxidative Stress and Kidney Injury.维生素 C 和铜联合给药诱导全身氧化应激和肾脏损伤。
Biomolecules. 2023 Jan 10;13(1):143. doi: 10.3390/biom13010143.
6
Appropriate level of cuproptosis may be involved in alleviating pulmonary fibrosis.适当水平的铜死亡可能参与缓解肺纤维化。
Front Immunol. 2022 Dec 19;13:1039510. doi: 10.3389/fimmu.2022.1039510. eCollection 2022.